Literature DB >> 10860935

Pharmacological properties of 5-Hydroxytryptamine(4) receptor antagonists on constitutively active wild-type and mutated receptors.

S Claeysen1, M Sebben, C Bécamel, R M Eglen, R D Clark, J Bockaert, A Dumuis.   

Abstract

We studied the pharmacological properties of twenty-four 5-hydroxytryptamine (5-HT)(4) receptor ligands known to act as antagonists on 5-HT(4) receptors positively coupled to adenylyl cyclase endogenously expressed in mouse colliculi neurons. In COS-7 cells expressing human or mouse 5-HT(4(a)) receptors (100-8000 fmol/mg of protein), we found neutral antagonists, partial agonists, and inverse agonists. The majority of neutral antagonists belong to the benzodioxanyl ketone class, whereas partial agonists belong to different chemical classes. We found only two inverse agonists, GR 125487 and SB 207266, which are both indoles. Analysis of pharmacological characteristics of the constitutively active wild-type and constitutively active mutated receptors revealed that 1) the ratio between the efficiencies of the full agonist 5-HT and the partial agonist RS 23597 was invariable when the receptor density increased, but was dependent on receptor structure; 2) similarly, the efficacy of the inverse agonist SB 207266 was not dependent on receptor density but was dependent on receptor structure; 3) when the receptor concentration increased, the EC(50) values of the full agonist 5-HT were not modified and the increase in basal constitutive activity, as well as its stimulation by 5-HT, followed a parallel evolution; and 4) the stimulation of basal constitutive activity by 5-HT was not modified by the overexpression of Galphas. All these results indicate that in COS-7 cells, the coupling of the 5-HT(4) receptor to adenylyl cyclase was linear with no indication of spare receptors even at high receptor density (8 pmol/mg). These results are also in accordance with a precoupling between the activated receptor (f(R*)) and adenylyl cyclase. Such observations allowed us to use the two-state model to calculate the constant J, i.e., the equilibrium allosteric constant denoting the ratio of the receptor in the inactive versus active state (J = [R]/[R*]). We found that J was a receptor structural characteristic, independent of receptor density.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860935     DOI: 10.1124/mol.58.1.136

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Constitutively active mutants of 5-HT4 receptors are they in unique active states?

Authors:  S Claeysen; M Sebben; C Bécamel; M L Parmentier; A Dumuis; J Bockaert
Journal:  EMBO Rep       Date:  2001-01       Impact factor: 8.807

Review 2.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

3.  The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.

Authors:  Kurt A Krobert; Finn Olav Levy
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 4.  Matching models to data: a receptor pharmacologist's guide.

Authors:  David A Hall; Christopher J Langmead
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Synaptic plasticity in myenteric neurons of the guinea-pig distal colon: presynaptic mechanisms of inflammation-induced synaptic facilitation.

Authors:  Eric M Krauter; David R Linden; Keith A Sharkey; Gary M Mawe
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

Review 6.  5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.

Authors:  Stephanie W Watts; Robert Patrick Davis
Journal:  Cardiovasc Ther       Date:  2011-02       Impact factor: 3.023

7.  Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon.

Authors:  Stephanie N Spohn; Francesca Bianco; Rachel B Scott; Catherine M Keenan; Alisha A Linton; Conor H O'Neill; Elena Bonora; Michael Dicay; Brigitte Lavoie; Rebecca L Wilcox; Wallace K MacNaughton; Roberto De Giorgio; Keith A Sharkey; Gary M Mawe
Journal:  Gastroenterology       Date:  2016-07-29       Impact factor: 22.682

8.  Variable Dependence of Signaling Output on Agonist Occupancy of Ste2p, a G Protein-coupled Receptor in Yeast.

Authors:  Rajashri Sridharan; Sara M Connelly; Fred Naider; Mark E Dumont
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

Review 9.  How Does the Brain Implement Adaptive Decision Making to Eat?

Authors:  Valérie Compan; B Timothy Walsh; Walter Kaye; Allan Geliebter
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

10.  Modifying ligand-induced and constitutive signaling of the human 5-HT4 receptor.

Authors:  Wei Chun Chang; Jennifer K Ng; Trieu Nguyen; Lucie Pellissier; Sylvie Claeysen; Edward C Hsiao; Bruce R Conklin
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.